Value of direct immunofluorescence in predicting remission in pemphigus vulgaris

International Journal of Dermatology

Volumn 45, Issue 11, 2006, Pages 1308-1311

  Balighi, Kamran ^a   Taheri, Arash ^a   Mansoori, Parisa ^a   Chams, Cheida ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PEMPHIGUS VULGARIS; PREDICTION; RELAPSE; REMISSION; RETROSPECTIVE STUDY;

ADULT; AGED; ANIMALS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; PROGNOSIS; REMISSION INDUCTION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SKIN; TIME FACTORS;

EID: 33750624160     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.02916.x     Document Type: Article

References (11)

1. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus-an update. Arch Dermatol 1996; 132: 203-212.
2. Ahmed AR, Moy R. Death in pemphigus. J Am Acad Dermatol 1982; 7: 221-228.
3. Judd KP, Lever WF. Correlation of antibodies in skin and serum with disease severity in pemphigus. Arch Dermatol 1979; 115: 428-432.
4. Ljubojevic S, Lipozencic J, Brenner S, et al. Pemphigus vulgaris: A review of treatment over a 19-year period. J Eur Acad Dermatol Venereol 2002; 16: 599-603.
5. Ratnam KV, Pang BK. Pemphigus in remission: Value of negative direct immunofluorescence in management. J Am Acad Dermatol 1994; 30: 547-550.
6. David M, Weissman-Katzenelson V, Ben-Chetrit A, et al. The usefulness of immunofluorescent tests in pemphigus patients in clinical remission. Br J Dermatol 1989; 120: 391-395.
7. Mourellou O, Chaidemenos GC, Koussidou T, et al. The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period. Br J Dermatol 1995; 133: 83-87.
8. Herbst A, Bystryn JC. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol 2000; 42: 422-427.
9. Kricheli D, David M, Frusic-Zlotkin M, et al. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives. Br J Dermatol 2000; 143: 337-342.
10. Bhol K, Mohimen A, Ahmed R. Correlation of subclasses of IgG with disease activity in pemphigus vulgaris. Dermatologica 1994; 189: 85-89.
11. O'Loughlin S, Goldman GC, Provost TT. Fate of pemphigus antibody following successful therapy. Preliminary evaluation of pemphigus antibody determinations to regulate therapy. Arch Dermatol 1978; 114: 1769-1772.